Pulmonx (LUNG) Change in Acquisitions & Divestments (2019 - 2025)
Pulmonx's (LUNG) quarterly Change in Acquisitions & Divestments came in at $8.8 million in Q3 2025, down 30.98% year-on-year from $12.8 million in Q3 2024, and up 21.38% on a QoQ basis from $7.2 million in Q2 2025.
Pulmonx (LUNG) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $8.8 million in Q3 2025.
- On a quarterly basis, Change in Acquisitions & Divestments fell 30.98% year-over-year to $8.8 million in Q3 2025; TTM through Sep 2025 was $52.3 million, a 56.39% increase from a year earlier, with the FY2024 full-year figure at $46.8 million, up 4.08% from the prior year.
- Change in Acquisitions & Divestments for Q3 2025 stood at $8.8 million, up from $7.2 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for LUNG reached as high as $20.5 million in Q1 2025 and fell as low as $2.2 million in Q4 2023.
- Historically, Change in Acquisitions & Divestments has averaged $10.2 million across 5 years, with a median of $10.8 million in 2022.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 76.92% in 2023 and surged 596.53% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $3.0 million in 2021, then soared by 225.0% to $9.8 million in 2022, then slumped by 76.92% to $2.2 million in 2023, then jumped by 596.53% to $15.7 million in 2024, then plunged by 43.85% to $8.8 million in 2025.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $8.8 million in Q3 2025, $7.2 million in Q2 2025, and $20.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.80 Mn |
| Sep 30, 2025 | 8.80 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 20.54 Mn |
| Mar 31, 2025 | 20.54 Mn |
| Dec 31, 2024 | 15.67 Mn |
| Dec 31, 2024 | 15.67 Mn |
| Sep 30, 2024 | 12.75 Mn |
| Sep 30, 2024 | 12.75 Mn |
| Jun 30, 2024 | 6.67 Mn |
| Jun 30, 2024 | 6.67 Mn |
| Mar 31, 2024 | 11.75 Mn |
| Mar 31, 2024 | 11.75 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Jun 30, 2023 | 11.75 Mn |
| Jun 30, 2023 | 11.75 Mn |